ライフサイエンスコーパス: did not differ

1 Rates of grade 3-4 adverse events did not differ among regimens (P = .37).

2 Outcomes did not differ among test and control groups.

3 The reactivity of IgE antibody to the extracted protein did not differ among the different processed food types.

4 Expressive language scores did not differ at 18 mo (P = 0.236) but were higher in the LN

5 Total number of possible abnormalities did not differ between cases and controls.

6 Microbial diversity measures did not differ between food sensitization and food allergy ca

7 d preference in response to low-dose cocaine administration did not differ between genotypes.

8 The rate of stent thrombosis, a safety indicator, did not differ between groups and was low in both treatment g

9 Age and basal glomerular filtration rate did not differ between groups.

10 and neurodevelopmental assessments at 18 to 24 months' PMA did not differ between groups.

11 hysical activity, 24-h glycemia, and 24-h insulin secretion did not differ between intervention days.

12 expression levels of AROM, estrogen and androgen receptors did not differ between males and females and were not sex-spe

13 Oral food intake did not differ between the 2 groups.

14 Overall and serious adverse events did not differ between the flecainide and placebo arms.

15 ions performed by nonexperts (primarily residents, n = 290) did not differ between the groups (84.4% with video laryngosc

16 s adverse reactions were recorded and other safety measures did not differ between the groups, after allowing for missing

17 edian overall survival in the intention-to-treat population did not differ between the treatment groups: 7.7 months (95%

18 verse events, mostly mild self-limited joint and back pain, did not differ between the yoga and PT groups.

19 The overall rate of serious adverse events did not differ between treatment groups, although some specif

20 stochemistry showed that HOXB13 gene and protein expression did not differ between tumour samples from variant and wild-t

21 posed infants; clinical outcomes for truly infected infants did not differ by strategy.

22 Antibiotic prescription fills did not differ for persons with versus without risk factors f

23 ng inverted-repeat stable transformants (irAGO8) plants but did not differ from the wild type when consuming plants silen

24 Lymphatic vessel density in CLAD patients did not differ from those in control subjects (median number

25 he control level, Podo-GC-A KO mice and control littermates did not differ in BP, GFR, or natriuresis under baseline cond

26 Vitamin D and placebo groups did not differ in change in insulin sensitivity (0.02 +/- 2.0

27 The 'real' and 'sham' groups did not differ in online working memory task performance, but

28 few exceptions, Topt and Ea of denitrification and anammox did not differ in Rhode Island sediments over the seasonal cy

29 tramadol ER (7 [19.4%]), or buprenorphine (3 [9.7%]) groups did not differ significantly (chi2 = 2.5, P = .29).

30 f reducing sugars, ethanol, acetic acid, and amino nitrogen did not differ significantly (p<0.05) between co-inoculation

31 to PrEP, the efficacy of daily oral PrEP for HIV prevention did not differ significantly among women with abnormal versus

32 tal bacteria and individual species counts in dental plaque did not differ significantly between baseline and 3 months in

33 ence 0.3%, 95% CI -0.8 to 1.5; p=0.566) and neonatal deaths did not differ significantly between groups (six [2.0%] vs th

34 absolute difference, -0.6%; 95% CI, -1.8% to 0.6%; P = .51) did not differ significantly between groups.

35 n, and serious adverse events, as well as 28-day mortality, did not differ significantly between groups.

36 tes of complete remission and the composite renal end point did not differ significantly between groups.

37 Cortical thickness did not differ significantly between multiple sclerosis subje

38 Times of disease-free survival and overall survival did not differ significantly between patients with PDACs with

39 Overall survival at 4 years did not differ significantly between the transplantation grou

40 The rate of symptomatic intracranial hemorrhage did not differ significantly between the two groups (6% in th

41 er, medullary thyroid carcinoma, and serious adverse events did not differ significantly between the two groups.

42 T and creatine kinase, and the rates of bleeding and stroke did not differ significantly between the two groups.

43 HIV infection and mortality did not differ significantly by duration of breastfeeding (3.

44 Noncardiac and any cardiac deaths did not differ significantly by treatment.

45 Three-year RFS and OS did not differ significantly for patients in the R-CHOP or in

46 ents with irregular Z line and patients with BE of >/= 1 cm did not differ significantly in age, race, or duration of fol

47 The groups did not differ significantly on any measure of psychopatholog

48 Patients with or without linear lesions did not differ significantly with respect to sex, age, and cu

49 entified correctly with a dose of 2 MBq/kgBW; Likert scores did not differ significantly.

50 and 5.3 per 100000 births in the EOS calculator period) and did not differ statistically (P = .70).